Latest Partnerships News

African Gold Ltd has kicked off its largest-ever 40,000-metre drilling program at the Didievi Gold Project in Côte d'Ivoire, aiming to build on a recently defined near-surface 989,000-ounce gold resource.

FINEOS Corporation Holdings PLC reports steady revenue growth and operational efficiencies in Q2 2025, alongside new client contracts in North America that bolster its outlook for positive free cash flow this fiscal year.

Nimy Resources reports impressive high-grade gallium assays from its Block 3 East drilling campaign, advancing towards a maiden JORC-compliant resource at the Mons Project. The company also strengthens its metallurgical research partnerships and secures fresh capital to fuel ongoing exploration.

Toubani Resources has made significant strides in developing its Kobada Gold Project in Mali, securing a $29 million strategic placement and launching extensive drilling programs aimed at expanding its mineral resource base ahead of a final investment decision.

Artrya has launched its AI-powered Salix Coronary Anatomy platform in the U.S. and submitted its Coronary Plaque module for FDA clearance, marking a key step in its commercial expansion. A new five-year contract with Tanner Health signals the start of U.S. revenues.

Proteomics International Laboratories has secured $12 million to fast-track its precision diagnostic tests, including the US launch of PromarkerD for diabetic kidney disease, backed by a new AMA billing code. The company also advances its pipeline with new patents and commercial partnerships.

Viridis Mining and Minerals has locked in a strategic US$30 million equity funding partnership with leading Brazilian asset managers to accelerate its Colossus Rare Earth Project towards production.

OD6 Metals has reported strong high-grade copper results from its maiden drilling at Gulf Creek, NSW, alongside progress in rare earth metallurgical testing and closure of a regulatory investigation.

Elanor Investors Group announces a $125 million strategic investment from Rockworth Capital Partners to stabilise its balance sheet and fund growth, including the acquisition of Singapore’s Firmus Capital.

Elanor Investors Group announces a $125 million recapitalisation through an expanded alliance with Rockworth Capital Partners, including the acquisition of Singapore’s Firmus Capital and a strategic shift towards Pan-Asian real estate markets.

Develop Global Limited has marked a pivotal quarter with initial concentrate shipments from its Woodlawn Copper-Zinc Mine, the commencement of earthworks at Sulphur Springs, and a substantial A$180 million capital raise to fuel an aggressive growth strategy.

Radiopharm Theranostics has received FDA clearance to begin a Phase I clinical trial for RV-01, a novel radiopharmaceutical targeting the 4Ig isoform of B7-H3 in solid tumors, marking a significant step forward in cancer treatment innovation.